Elevian
Allston
About Elevian
Elevian’s founders discovered circulating blood factors that regulate aging, including GDF11, which broadly stimulate regeneration of brain, heart, pancreas, muscle, and other tissues. Elevian is developing therapeutics that stimulate regenerative capacity, to treat and prevent age-related disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $64.3M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2021)
- Website: elevian.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/elevian-38556 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.